Built for her biology,
not his marketing.
The evidence-based, non-commercial guide to supplements and claims marketed at women.
Anxiety / Mood
The generic 'adaptogen' pick everyone reaches for isn't the one with cycle-specific evidence behind it.
The most popular anxiety-supplement herb by far. Meta-analyses of RCTs show real reductions in stress, anxiety scores, and cortisol — but these trials are run in mixed-sex, general-stress populations, not tied to the menstrual cycle.
Has direct randomized trial evidence in women specifically for PMDD — a condition where mood symptoms are tied to the luteal phase, not general daily stress.
What it is, and why people take it
Ashwagandha and saffron are both herbal extracts studied for anxiety and mood.
Ashwagandha is an adaptogen believed to lower cortisol and calm the stress response; saffron (Crocus sativus) affects serotonin pathways and has a more specific body of research in cyclical mood symptoms.
People take either for everyday stress and low mood — but the trial evidence for each sits in different places.
Why this happens
Multiple meta-analyses of ashwagandha RCTs — pooling nearly a thousand participants across studies — show statistically significant reductions in stress, anxiety scores, and serum cortisol compared to placebo. This is genuinely solid evidence, but it comes from general-population, mostly mixed-sex stress and anxiety trials, not research targeted at cyclical or hormone-linked mood symptoms.
Saffron has a narrower but more targeted evidence base: a randomized controlled trial of 120 women diagnosed with PMDD found saffron performed comparably to fluoxetine (an SSRI) in reducing PMDD mood symptoms, with fewer side effects than the medication. A separate RCT in women with mild-to-moderate anxiety found a saffron-and-ashwagandha combination improved mood outcomes. If your anxiety or mood symptoms track your cycle specifically, saffron has evidence aimed at that pattern in a way generic ashwagandha marketing doesn't.
Worth knowing: the saffron+ashwagandha combination study was funded by Laboratories Ordesa S.L. as the study's promotor. The finding may still be valid, but it isn't independently funded research.
What to look for instead
- If your mood symptoms are cycle-linked (worse in the luteal phase, better after your period starts), saffron has the more directly relevant trial evidence — specifically extracts standardized as 'affron®,' the branded extract used in the published RCTs.
- If your stress is constant, not cyclical, ashwagandha's evidence base is broader and better-established for general stress and cortisol.
- Saffron is not a substitute for treatment of diagnosed PMDD or clinical depression — the trial showing comparable results to an SSRI doesn't mean it's interchangeable with prescribed treatment without medical guidance.
- Neither is fast-acting — meaningful effects in the trials above took 4–8 weeks of consistent use, not days.
A note on age
These trials were conducted in adult women. Persistent anxiety or mood symptoms in a teenager deserve a conversation with a doctor or therapist rather than a supplement — this page is not a substitute for that evaluation, especially where mood is involved.
Where to buy
What buying the best-seller implies
A popular, well-reviewed generic saffron extract.
What the evidence actually shows
Not the specific 'affron®' branded extract used in the PMDD trials, so the exact evidence doesn't transfer one-to-one.
Most popular pick
Evidence-based for women
Uses the affron® standardized extract — the specific formulation studied in the PMDD and mood RCTs cited above, not just generic saffron.
Cost breakdown
The same per-serving prices, at a day.
Switching from the most popular pick to an evidence-based one costs about $1.20 more a month.
Sources 4 studies · show list
- Rajabi, Rahimi, Sharbafchizadeh, Tarrahi (2020). Saffron for the Management of Premenstrual Dysphoric Disorder: A Randomized Controlled Trial. Advanced Biomedical Research. PubMed 33457343
- Pages-García, De Almagro, Ruiz-Moreno, De Castellar (2024). Effectiveness of a Saffron and Withania Supplement on Mood in Women With Mild-to-Moderate Anxiety. PMC11919007
- Akhgarjand, Asoudeh, Bagheri, Kalantar, Vahabi, Shab-Bidar, Djafarian (2022). Does Ashwagandha supplementation have a beneficial effect on the management of anxiety and stress? Systematic review and meta-analysis of RCTs. Phytotherapy Research. PubMed 36017529
- Arumugam, Vijayakumar, Balakrishnan, Bhandari, Boopalan, Ponnurangam, Sankaralingam Thirupathy, Kuppusamy (2024). Effects of Ashwagandha (Withania Somnifera) on stress and anxiety: A systematic review and meta-analysis. Explore. PubMed 39348746